S. Brode

Most-cited papers

1. Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: an individual patient data meta-analysis

   N. Ahmad, S. Ahuja, O. Akkerman, J. Alffenaar +104 more

   2018The Lancet494 citations Open access

   Semantic Scholar

   Save

2. Drug-associated adverse events in the treatment of multidrug-resistant tuberculosis: an individual patient data meta-analysis

   Zhi-Yi Lan, N. Ahmad, P. Baghaei, Linda Barkāne +18 more

   2020The Lancet Respiratory Medicine212 citations Open access

   Semantic Scholar

   Save

3. The epidemiologic relationship between tuberculosis and non-tuberculous mycobacterial disease: a systematic review.

   S. Brode, C. Daley, T. Marras

   2014The International Journal of Tuberculosis and Lung Disease204 citations

   Semantic Scholar

   Save

4. Increased risk of mycobacterial infections associated with anti-rheumatic medications

   S. Brode, F. Jamieson, R. Ng, M. Campitelli +6 more

   2015Thorax155 citations Open access

   Semantic Scholar

   Save

5. The risk of mycobacterial infections associated with inhaled corticosteroid use

   S. Brode, M. Campitelli, J. Kwong, Hong Lu +4 more

   2017European Respiratory Journal145 citations Open access

   Semantic Scholar

   Save

6. Alpha-1 antitrypsin deficiency: a commonly overlooked cause of lung disease

   S. Brode, S. Ling, K. Chapman

   2012Canadian Medical Association Journal104 citations Open access

   Semantic Scholar

   Save

7. Pulmonary Nontuberculous Mycobacteria–Associated Deaths, Ontario, Canada, 2001–2013

   T. Marras, M. Campitelli, Hong Lu, H. Chung +6 more

   2017Emerging Infectious Diseases79 citations Open access

   Semantic Scholar

   Save

8. Standardised shorter regimens versus individualised longer regimens for rifampin- or multidrug-resistant tuberculosis

   Syed Abidi, J. Achar, M. Assao-Neino, D. Bang +33 more

   2019European Respiratory Journal74 citations Open access

   Semantic Scholar

   Save

9. Pulmonary versus Nonpulmonary Nontuberculous Mycobacteria, Ontario, Canada

   S. Brode, A. Marchand-Austin, F. Jamieson, T. Marras

   2017Emerging Infectious Diseases68 citations Open access

   Semantic Scholar

   Save

10. Risk of mycobacterial infections associated with rheumatoid arthritis in Ontario, Canada.

    S. Brode, F. Jamieson, R. Ng, M. Campitelli +6 more

    2014Chest59 citations

    Semantic Scholar

    Save

11. Risk of nontuberculous mycobacterial pulmonary disease with obstructive lung disease

    T. Marras, M. Campitelli, J. Kwong, Hong Lu +4 more

    2016European Respiratory Journal34 citations Open access

    Semantic Scholar

    Save

12. Dual therapy in IPAH and SSc-PAH. A qualitative systematic review.

    S. Johnson, S. Brode, L. Mielniczuk, J. Granton

    2012Respiratory Medicine30 citations Open access

    Semantic Scholar

    Save

13. Surgical Site Infection Affects Length of Stay After Complex Head and Neck Procedures

    N. Lebo, A. Quimby, L. Caulley, K. Thavorn +3 more

    2020The Laryngoscope25 citations

    Semantic Scholar

    Save

14. Safety and effectiveness of low-dose amikacin in nontuberculous mycobacterial pulmonary disease treated in Toronto, Canada

    M. Aznar, T. Marras, A. Elshal, Mahtab Mehrabi +1 more

    2019BMC Pharmacology and Toxicology25 citations Open access

    Semantic Scholar

    Save

15. Low-dose amikacin in the treatment of Multidrug-resistant Tuberculosis (MDR-TB)

    Natasha F. Sabur, M. Brar, Lisa Wu, S. Brode

    2021BMC Infectious Diseases23 citations Open access

    Semantic Scholar

    Save

16. Multidrug-resistant tuberculosis: Treatment and outcomes of 93 patients.

    S. Brode, R. Varadi, J. McNamee, N. Malek +3 more

    2015Canadian Respiratory Journal20 citations Open access

    Semantic Scholar

    Save

17. Impact of Covid-19 on Tuberculosis Prevention and Treatment in Canada: a multicentre analysis of 10,833 patients

    C. Geric, M. Saroufim, David Landsman, J. Richard +4 more

    2021Journal of Infectious Diseases18 citations Open access

    Semantic Scholar

    Save

18. Clinical outcomes in Mycobacterium xenopi versus Mycobacterium avium complex pulmonary disease: A retrospective matched cohort study.

    A. Zaheen, T. Hirama, M. Mehrabi, S. Brode +1 more

    2020Respiratory Medicine16 citations Open access

    Semantic Scholar

    Save

19. Adjuvant lung resection in the management of nontuberculous mycobacterial lung infection: A retrospective matched cohort study.

    M. Aznar, M. Zubrinic, M. Siemienowicz, K. Hashimoto +5 more

    2018Respiratory Medicine16 citations Open access

    Semantic Scholar

    Save

20. Characteristics, treatment and outcomes of nontuberculous mycobacterial pulmonary disease after allogeneic haematopoietic stem cell transplant

    T. Hirama, S. Brode, Jenifer Beswick, A. Law +8 more

    2018European Respiratory Journal15 citations Open access

    Semantic Scholar

    Save

21. Chapter 8: Drug-resistant tuberculosis

    S. Brode, R. Dwilow, D. Kunimoto, D. Menzies +1 more

    2022Canadian Journal of Respiratory Critical Care and Sleep Medicine14 citations Open access

    Semantic Scholar

    Save

22. Risk factors for drug-resistant tuberculosis at a referral centre in Toronto, Ontario, Canada: 2010-2016.

    T. Hirama, Natasha F. Sabur, P. Derkach, J. McNamee +3 more

    2020Canada communicable disease report = Releve des maladies transmissibles au Canada14 citations Open access

    Semantic Scholar

    Save

23. Pulmonary Nontuberculous Mycobacteria, Ontario, Canada, 2020

    T. Marras, Paul L. Nelson, A. Peci, Melissa Richard-Greenblatt +4 more

    2023Emerging Infectious Diseases13 citations Open access

    Semantic Scholar

    Save

24. Costs of Tuberculosis at 3 Treatment Centers, Canada, 2010–2016

    Jonathon R. Campbell, Placide Nsengiyumva, L. Chiang, F. Jamieson +12 more

    2022Emerging Infectious Diseases13 citations Open access

    Semantic Scholar

    Save

25. Evaluation of Mycobacterium avium complex pulmonary disease treatment completion and adherence to ATS/IDSA guidelines.

    J. Ku, E. Henkle, K. Carlson, M. Marino +3 more

    2022Clinical Infectious Diseases13 citations

    Semantic Scholar

    Save

26. Safety and effectiveness of clofazimine in nontuberculous mycobacterial lung disease

    M. Aznar, S. Brode, Mahtab Mehrabi, T. Marras

    201813 citations

    Semantic Scholar

    Save

27. Association of Indicators of Extensive Disease and Rifampin-Resistant Tuberculosis Treatment Outcomes: An Individual Participant Data Meta-Analysis

    Jonathon R. Campbell, S. Brode, P. Barry, M. Bastos +12 more

    2023Thorax12 citations Open access

    Semantic Scholar

    Save

28. "The other nontuberculous mycobacteria (NTM): Clinical aspects of lung disease caused by less common slow-growing NTM species".

    M. Yan, S. Brode, T. Marras

    2022Chest12 citations

    Semantic Scholar

    Save

29. Time to Positive Culture Detection Predicts Mycobacterium avium Pulmonary Disease Severity and Treatment Initiation.

    B. Edwards, S. Brode, Mahtab Mehrabi, T. Marras

    2021Annals of the American Thoracic Society10 citations

    Semantic Scholar

    Save

30. Costs Associated with Nontuberculous Mycobacteria Infection, Ontario, Canada, 2001–2012

    L. Ramsay, E. Shing, John Wang, T. Marras +4 more

    2020Emerging Infectious Diseases10 citations Open access

    Semantic Scholar

    Save

31. Outcomes of a Peri and Post-operative management protocol for Nontuberculous mycobacteria in lung transplant recipients.

    T. Hirama, L. Singer, S. Brode, T. Marras +1 more

    2020Chest10 citations Open access

    Semantic Scholar

    Save

32. Underutilization of nontuberculous mycobacterial drug susceptibility testing in Ontario, Canada, 2010-2015.

    E. R. Andrews, A. Marchand-Austin, Jennifer H. Ma, Kirby Cronin +4 more

    2020Journal of the Association of Medical Microbiology and Infectious Disease Canada = Journal officiel de l'Association pour la microbiologie medicale et l'infectiologie Canada10 citations Open access

    Semantic Scholar

    Save

33. Hepatotoxicity and tuberculosis treatment outcomes in chronic liver disease.

    B. Edwards, H. Mah, Natasha F. Sabur, S. Brode

    2023Journal of the Association of Medical Microbiology and Infectious Disease Canada = Journal officiel de l'Association pour la microbiologie medicale et l'infectiologie Canada9 citations Open access

    Semantic Scholar

    Save

34. Clinical efficacy and safety of fluoroquinolone containing regimens in patients with Mycobacterium avium complex pulmonary disease

    Hadeel A. Khadawardi, T. Marras, Mahtab Mehrabi, S. Brode

    2020European Respiratory Journal9 citations Open access

    Semantic Scholar

    Save

35. Mycobacterium xenopi Genotype Associated with Clinical Phenotype in Lung Disease

    T. Hirama, A. Marchand-Austin, Jennifer H. Ma, D. Alexander +3 more

    2018Lung8 citations

    Semantic Scholar

    Save

36. External validation of the BACES Score in Canadian patients with nontuberculous mycobacterial pulmonary disease.

    Marie Yan, Brooke Fraser, E. McArthur, M. Mehrabi +2 more

    2023Chest6 citations

    Semantic Scholar

    Save

37. Increasing and More Commonly Refractory Mycobacterium avium Pulmonary Disease, Toronto, Ontario, Canada

    D. Raats, S. Brode, Mahtab Mehrabi, T. Marras

    2022Emerging Infectious Diseases6 citations Open access

    Semantic Scholar

    Save

38. Radiologic types of Mycobacterium xenopi pulmonary disease: different patients with similar short-term outcomes

    T. Hirama, S. Brode, T. Marras

    2018European Journal of Clinical Microbiology and Infectious Diseases6 citations

    Semantic Scholar

    Save

39. Multilocus Sequence Typing of Mycobacterium xenopi

    D. Alexander, T. Marras, Jennifer H. Ma, Samia Mirza +8 more

    2014Journal of Clinical Microbiology6 citations Open access

    Semantic Scholar

    Save

40. Treatment outcomes of nontuberculous mycobacterial pulmonary disease in lung transplant recipients

    T. Hirama, L. Singer, S. Brode, T. Marras +1 more

    2021Transplant Infectious Disease5 citations

    Semantic Scholar

    Save

41. Phenotypic amikacin resistance may not indicate poor response to amikacin in Mycobacterium avium complex pulmonary disease

    L. Minuk, S. Brode, M. Mehrabi, Mayank Mohan Sharma +3 more

    2024Antimicrobial Agents and Chemotherapy4 citations Open access

    Semantic Scholar

    Save

42. Treatment of the Less Common Nontuberculous Mycobacterial Pulmonary Disease.

    M. Yan, S. Brode, T. Marras

    2023Clinics in Chest Medicine4 citations

    Semantic Scholar

    Save

43. Tuberculin skin tests and interferon-γ release assays in the diagnosis of tuberculosis infection

    M. Yan, Jonathon R. Campbell, T. Marras, S. Brode

    2023Canadian Medical Association Journal4 citations Open access

    Semantic Scholar

    Save

44. Aspergillus isolation in nontuberculous mycobacterial pulmonary disease: Associated with antimycobacterial treatment initiation but not response.

    D. Raats, S. Aldhaheri, T. Marras, Mahtab Mehrabi +1 more

    2021Respiratory Medicine4 citations Open access

    Semantic Scholar

    Save

45. The impact of different antibiotic treatment regimens on mortality in Mycobacterium avium complex pulmonary disease: a population-based cohort study

    S. Brode, H. Chung, M. Campitelli, J. Kwong +5 more

    2020European Respiratory Journal4 citations Open access

    Semantic Scholar

    Save

46. Prescribing Patterns for Treatment of Mycobacterium avium Complex and M. xenopi Pulmonary Disease in Ontario, Canada, 2001–2013

    S. Brode, H. Chung, M. Campitelli, J. Kwong +4 more

    2019Emerging Infectious Diseases4 citations Open access

    Semantic Scholar

    Save

47. Nontuberculous Mycobacterial Disease in Solid-Organ Transplant Recipients and the General Population

    Seyed M. Hosseini-Moghaddam, D. Fridman, S. Drover, T. Marras +4 more

    2025JAMA Network Open3 citations

    Semantic Scholar

    Save

48. The Canadian Bronchiectasis and Nontuberculous Mycobacteria Registry: a study protocol

    Christina S. Thornton, N. Boechler, Vidhi Desai, R. Somayaji +6 more

    2024ERJ Open Research3 citations Open access

    Semantic Scholar

    Save

49. Tolerability outcomes of ATS/IDSA guideline-recommended multi-drug antibiotic treatment for Mycobacterium avium complex pulmonary disease in U.S. Medicare beneficiaries with bronchiectasis.

    J. H. Ku, E. Henkle, Kathleen F. Carlson, Miguel Marino +3 more

    2023Chest3 citations

    Semantic Scholar

    Save

50. Association of smoking and alcohol use with rifampin-resistant TB treatment outcomes.

    J. R. Campbell, E. D. Chan, L. F. Anderson, M. Bonnet +10 more

    2023The International Journal of Tuberculosis and Lung Disease2 citations

    Semantic Scholar

    Save